is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Could GLP-1 Weight Loss Drugs

the prevalence of migraine increases with age, with a high incidence in late adolescence and peaking in early adulthood

The model results support the discussion in [13] of why this is so

I finally realized that diet and exercise alone were not enough to overcome genetics and my weight issues

YangQXiangYMaGCaoMFangYXuWet al

This table outlines key hormonal conditions and their potential relationship to medication tolerability, supporting more intentional provider conversations about timing and dosage adjustments

The weight loss was a fortuitous side effect because semaglutide was originally designed to be a treatment for diabetes